Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
AGTC completes enrollment in highest dose groups of Phase 1/2 trial of AGTC-501 » 07:04
02/19/20
02/19
07:04
02/19/20
07:04
AGTC

Applied Genetic

$5.40 /

+0.29 (+5.68%)

Applied Genetic…

Applied Genetic Technologies announced that it has completed enrollment in the two highest dose groups of its Phase 1/2 clinical trial evaluating the safety and efficacy of sub-retinal injection of AGTC-501 for the treatment of X-linked retinitis pigmentosa caused by mutations in the RPGR gene. The patients in these additional groups received a higher or highest dose of AGTC's XLRP candidate.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Applied Genetic in position to execute after cash raise, says Roth Capital » 12:10
02/12/20
02/12
12:10
02/12/20
12:10
AGTC

Applied Genetic

$5.22 /

+0.08 (+1.56%)

Roth Capital analyst…

Roth Capital analyst Zegbeh Jallah said 2019 "was a good year" for Applied Genetic Technologies that has been followed by a strong start in 2020 with positive 6-month interim data for XLRP announced in January. A recent cash raise positions Applied "to fully execute on all fronts," contends Jallah, who remains bullish on the stock as she looks forward to updated results from the company's two lead programs before year-end. Jallah has a Buy rating on Applied Genetic Technologies shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Applied Genetic 6.5M share Spot Secondary priced at $5.00 » 20:07
02/06/20
02/06
20:07
02/06/20
20:07
AGTC

Applied Genetic

$5.71 /

-1.285 (-18.38%)

The deal size was…

The deal size was increased from 6.0M shares and priced below the last closing price of $5.71. Wells Fargo and Wedbush are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07
    Feb
Hot Stocks
Fly Intel: After Hours Movers » 19:00
02/05/20
02/05
19:00
02/05/20
19:00
RAMP

LiveRamp

$41.37 /

+0.54 (+1.32%)

, SONO

Sonos

$14.09 /

-0.48 (-3.29%)

, ELF

e.l.f. Beauty

$17.28 /

+0.15 (+0.88%)

, ACLS

Axcelis

$25.85 /

+0.62 (+2.46%)

, ARWR

Arrowhead

$44.00 /

+0.08 (+0.18%)

, CURO

Curo Group

$10.30 /

+0.72 (+7.52%)

, QNST

QuinStreet

$12.58 /

-0.39 (-3.01%)

, ZNGA

Zynga

$5.90 /

-0.175 (-2.88%)

, GLUU

Glu Mobile

$6.44 /

+0.19 (+3.04%)

, CENTA

Central Garden & Pet Co.

$30.02 /

+0.39 (+1.32%)

, FORM

FormFactor

$26.42 /

+0.02 (+0.08%)

, IRBT

iRobot

$49.23 /

+1.085 (+2.25%)

, NUAN

Nuance

$19.65 /

+0.19 (+0.98%)

, COHR

Coherent

$149.60 /

-2.265 (-1.49%)

, CSGS

CSG

$51.94 /

+0.96 (+1.88%)

, FOXA

Fox Corp.

$38.68 /

+0.66 (+1.74%)

, ENSG

Ensign Group

$47.80 /

+1.13 (+2.42%)

, SAVE

Spirit Airlines

$44.41 /

+1.065 (+2.46%)

, FLO

Flowers Foods

$21.72 /

-0.055 (-0.25%)

, LNC

Lincoln National

$57.99 /

+2.33 (+4.19%)

, CTSH

Cognizant

$65.01 /

+1.58 (+2.49%)

, GPRO

GoPro

$4.36 /

+0.205 (+4.93%)

, ENS

EnerSys

$77.54 /

+0.18 (+0.23%)

, ANGI

Angi Homeservices

$8.60 /

+0.06 (+0.70%)

, UHAL

Amerco

$370.48 /

-4.44 (-1.18%)

, CDAY

Ceridian

$73.30 /

-4.59 (-5.89%)

, PTON

Peloton

$32.55 /

-0.935 (-2.79%)

, TWO

Two Harbors

$15.52 /

+0.205 (+1.34%)

, TWLO

Twilio

$127.03 /

-4.76 (-3.61%)

, PAYC

Paycom

$320.31 /

-17.575 (-5.20%)

, FEYE

FireEye

$16.00 /

-0.05 (-0.31%)

, NTGR

Netgear

$25.96 /

+0.15 (+0.58%)

, YUMC

Yum China

$44.51 /

+0.285 (+0.64%)

, MXL

MaxLinear

$19.88 /

+0.84 (+4.41%)

, GRUB

GrubHub

$55.42 /

-0.64 (-1.14%)

, ICHR

Ichor Holdings

$35.66 /

-0.11 (-0.31%)

, QCOM

Qualcomm

$90.91 /

+1.97 (+2.21%)

, IAC

IAC

$238.83 /

-15.3 (-6.02%)

, MET

MetLife

$51.50 /

+1.32 (+2.63%)

, FNKO

Funko

$15.48 /

+0.42 (+2.79%)

, AGTC

Applied Genetic

$6.99 /

+0.5 (+7.70%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: LiveRamp (RAMP) up 10.4%... Sonos (SONO) up 9.9%... e.l.f. Beauty (ELF) up 8.7%... Axcelis Technologies (ACLS) up 7.2%... Arrowhead Pharma (ARWR) up 6.7%... Curo Group (CURO) up 6.2%... QuinStreet (QNST) up 6.2%... Zynga (ZNGA) up 5.2%... Glu Mobile (GLUU) up 4.5%... Central Garden & Pet (CENTA) up 4.3%... FormFactor (FORM) up 4.3%... Nuance Communications (NUAN) up 4.0%... Coherent (COHR) up 3.7%... CSG Systems (CSGS) up 3.4%... iRobot (IRBT) up 3.4%... Ensign Group (ENSG) up 3.3%... Fox Corp (FOXA) up 3.2%... Spirit Airlines (SAVE) up 2.4%... Flowers Foods (FLO) up 2.2%... Lincoln National (LNC) up 2.0%... Cognizant (CTSH) up 1.6%... DOWN AFTER EARNINGS: GoPro (GPRO) down 13.5%... EnerSys (ENS) down 12.9%... Angi Homeservices (ANGI) down 10.7%... Amerco (UHAL) down 10.3%... Ceridian HCM (CDAY) down 9.2%... Peloton (PTON) down 8.0%... Two Harbors (TWO) down 5.0%... Twilio (TWLO) down 4.7%... PayCom (PAYC) down 4.6%... FireEye (FEYE) down 4.5%... NetGear (NTGR) down 3.6%... Yum China (YUMC) down 3.0%... MaxLinear (MXL) down 2.6%... GrubHub (GRUB) down 2.0%... Ichor Holdings (ICHR) down 1.9%... Qualcomm (QCOM) down 1.8%... IAC (IAC) down 1.8%... MetLife (MET) down 1.6%. ALSO LOWER: Funko (FNKO) down 36.0% after below-consensus preliminary Q4 outlook... ION Geophysical Corp (IO) down 20.6%... Applied Genetic Technologies (AGTC) down 8.7% after equity offering... Movers as of 18:15ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07
    Feb
Syndicate
Applied Genetic files to sell 6M shares of common stock » 16:38
02/05/20
02/05
16:38
02/05/20
16:38
AGTC

Applied Genetic

$7.01 /

+0.52 (+8.01%)

Wells Fargo Securities,…

Wells Fargo Securities, LLC and Wedbush Securities Inc. are acting as joint book-running managers for the offering. H.C. Wainwright & Co., LLC is acting as lead manager for the offering. Janney Montgomery Scott LLC and Roth Capital Partners are acting as co-managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Applied Genetic files to offer 6M shares of common stock » 16:38
02/05/20
02/05
16:38
02/05/20
16:38
AGTC

Applied Genetic

$7.01 /

+0.52 (+8.01%)

Wells Fargo Securities,…

Wells Fargo Securities, LLC and Wedbush Securities Inc. are acting as joint book-running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Syndicate
Applied Genetic files to sell $35M in common stock  17:31
01/29/20
01/29
17:31
01/29/20
17:31
AGTC

Applied Genetic

$7.34 /

+0.03 (+0.41%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Fly Intel: Top five analyst initiations » 10:13
01/28/20
01/28
10:13
01/28/20
10:13
UBER

Uber

$36.57 /

+0.27 (+0.74%)

, INSP

Inspire Medical

$73.19 /

-5.31 (-6.76%)

, AGTC

Applied Genetic

$7.93 /

-0.07 (-0.88%)

, POR

Portland General Electric

$60.77 /

+0.175 (+0.29%)

, WWE

WWE

$60.37 /

+1.23 (+2.08%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Uber (UBER) initiated with a Buy at UBS. 2. Inspire Medical (INSP) initiated with an Underperform at Oppenheimer. 3. Applied Genetic (AGTC) initiated with a Buy at Roth Capital. 4. Portland General Electric (POR) initiated with a Sector Weight at KeyBanc. 5. WWE (WWE) initiated with a Buy at Northcoast. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Otonomy presents preclinical results for GJB2 collaboration, cisplatin program » 07:32
01/28/20
01/28
07:32
01/28/20
07:32
OTIC

Otonomy

$3.27 /

-0.045 (-1.36%)

, AGTC

Applied Genetic

$8.00 /

+0.605 (+8.18%)

Otonomy (OTIC) announced…

Otonomy (OTIC) announced preclinical results from the company's gene therapy collaboration with Applied Genetic Technologies Corporation (AGTC) focused initially on treating GJB2 deficiency for congenital hearing loss, and preclinical results demonstrating the therapeutic potential of a class of compounds being evaluated for otoprotection against cisplatin-induced hearing loss. These results were presented during the ongoing Association for Research in Otolaryngology 43rd Annual MidWinter Meeting being held in San Jose, California. In October 2019, Otonomy and AGTC announced a strategic collaboration to co-develop and co-commercialize an AAV-based gene therapy to restore hearing in patients with sensorineural hearing loss caused by a mutation in the gap junction protein beta 2 gene -- the most common cause of congenital hearing loss. The joint presentation by Otonomy and AGTC at ARO provided initial demonstration that a gene of interest can be expressed in support cells of the cochlea, which are the relevant target cells for treating GJB2 deficiency, using novel and proprietary AAV capsids. Furthermore, these studies identified several capsids with favorable tropism and gene expression level in support cells compared to previously reported capsids used in the field. Importantly, none of the novel AAV capsids evaluated for further development exhibited signs of cellular toxicity. Cisplatin is a potent chemotherapeutic agent that is widely used to treat a variety of cancers in adults and children. Unfortunately, the administration of cisplatin is commonly associated with severe adverse effects including CIHL that is progressive, bilateral and irreversible. At ARO, Otonomy presented preclinical results demonstrating varying degrees of otoprotection against CIHL for several different classes of therapeutic agents. In particular, a novel proprietary class of agents that potently bind to cisplatin demonstrated greater otoprotection than anti-oxidant and anti-apoptotic molecules, and increased potency relative to other cisplatin-binding molecules currently in clinical development. These results highlight the therapeutic potential of Otonomy's novel otoprotectant agents as the basis for the OTO-510 program for CIHL.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Applied Genetic to host R&D Day » 06:55
01/28/20
01/28
06:55
01/28/20
06:55
AGTC

Applied Genetic

$8.00 /

+0.605 (+8.18%)

R&D Day to be held in…

R&D Day to be held in New York on January 28 at 7:30 am. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.